Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Politics for Pros- moderated -- Ignore unavailable to you. Want to Upgrade?

To: Nadine Carroll who wrote (307042)	5/26/2009 5:34:45 PM
From: LindyBill	Read Replies (2) \| Respond to of 793846

She fills the "latin/woman" slot. And a slot it will be. She will be just another Liberal vote on the court, with no influence outside of her one vote. Thank God. The Right will be called "racist" if they rough her up too much. I think she will get by the Senate with about a 70/30 vote.

To: Nadine Carroll who wrote (307042)	11/11/2009 2:57:31 AM
From: Peter Dierks	2 Recommendations Read Replies (1) \| Respond to of 793846

Pfizer and Kelo's Ghost Town Pfizer bugs out, long after the land grab. NOVEMBER 11, 2009. The Supreme Court's 2005 decision in Kelo v. City of New London stands as one of the worst in recent years, handing local governments carte blanche to seize private property in the name of economic development. Now, four years after that decision gave Susette Kelo's land to private developers for a project including a hotel and offices intended to enhance Pfizer Inc.'s nearby corporate facility, the pharmaceutical giant has announced it will close its research and development headquarters in New London, Connecticut. The aftermath of Kelo is the latest example of the futility of using eminent domain as corporate welfare. While Ms. Kelo and her neighbors lost ... Message 26088464